In these studies, it was suggested that activation of OX40 receptor by agonistic antibody or OX40L transgenic tumor cells pushes regulatory T cells (Treg) in suppressing or depletion depending on the context of simulation and the cytokine milieu (65). This evidence concerns the gene TNFSF4 and neoplasm.